This article is normally republished with kind authorization from our close friends at The Kaiser Family Foundation. You will see the entire Kaiser Daily Health Policy Statement, search the archives, or join email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Daily Health Policy Report is released for Kaisernetwork.org, a free of charge program of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Organization and Kaiser Family Foundation. All rights reserved.. Colleges say new health law might imperil college student policies Kaiser Health News personnel writer Julie Appleby reviews on dilemma about how the new health law affects college health plans.Copyright 2009 Advisory Board Organization and Kaiser Family Base. All rights reserved.
BRI companions with French Authorities to make therapeutic antibodies for treatment of main diseases We are delighted to be dealing with such esteemed establishments to be able to generate cutting-edge therapeutic antibodies, stated Matthew Baker, chief scientific officer and co-founder of Antitope. This contract combines our partners’ experience in novel therapeutic strategies with Antitope’s experience in engineering humanized antibodies to develop therapeutic antibodies that may possess a substantial impact on the treating these major illnesses. This partnership will enable us to leverage Antitope’s exclusive technology in producing our therapeutic vaccines which might stand for a genuinely novel method of treating those illnesses having a significant unmet medical want, stated Jacques Banchereau, director of the Baylor Institute for Immunology Analysis , the individual immunology section of BRI.